![](/img/cover-not-exists.png)
A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas
Kim, Jeong Eun, Yoon, Dok Hyun, Jang, Geundoo, Lee, Dae Ho, Kim, Shin, Park, Chan-Sik, Huh, Jooryung, Kim, Won Seog, Park, Jinny, Lee, Jae Hoon, Lee, Soon Il, Suh, CheolwonVolume:
47
Year:
2012
Language:
english
Journal:
The Korean Journal of Hematology
DOI:
10.5045/kjh.2012.47.1.53
File:
PDF, 375 KB
english, 2012